Biomaterials SUMMIT Set for October 15th in New York City
BY ROBIN R. YOUNG CFA, MAY 24, 2004
It's been an extraordinary year for companies that employ or supply biomaterials. Sales are now running at a rate of $6 million per day and will, we believe, accelerate in 2005 with a new generation of growth factors, cartilage repair technologies, 'Super' allograft and stem cell technologies.
Today's biomaterials companies have captured $1.3 billion of the $20 billion orthopedic market. By 2020 biomaterials will be the therapy of choice for osteoporosis, arthritis and degenerative disc disease and be the largest single technology category in orthopedics.
To highlight and learn more about this growing and developing sector of Orthopedics, HealthpointCapital is excited to announce our Biomaterials Summit in New York, NY on October 15, 2004.
Look for more details, registration information and lists of the presenting companies in our upcoming HealthpointCapital Weekly Journal editions.
See you at the Summit!
